Lilly And Canadian VCs To Fund TVM Life Sciences VII To Develop Single-Asset Companies
This article was originally published in The Pink Sheet Daily
Executive Summary
Lilly and Canadian VCs back a new TVM Life Sciences fund that will invest in a network of single-asset companies in Quebec.